A new vaccine, produced by the Novavax Company, will be available to patients 12 years of age and older at health clinics countrywide in the coming days. Novavax’s protein-based technology joins the other options that are already available such as the Pfizer and Moderna vaccines. Many were skeptical of the other vaccines which are based on the relatively new, mRNA technology.
The new option presents an alternative to the mRNA vaccines, which many were skeptical of. The vaccine was found potent against several cases and various variants. It was approved by Israel’s vaccine council and health ministry, as well as by the leading global regulating bodies including the FDA, EMA, and MHRA, after those bodies studied the vaccine’s scientific data and decided that it is indeed effective against the virus. For those who were not yet vaccinated against Covid-19, the vaccine will be administered in two doses, 21 days apart.
The Novavax vaccine can also serve as a booster for patients who received two doses of another vaccine. A decision regarding a third dose for patients who received two doses of Novavax will be made in the future. The vaccine may be administered to patients who suffer from immunosuppression.
At the end of August, the US military announced that the Novavax vaccine will be made available to its personnel.
Here are some posts which will explain why the Novavax news, might be considered good news to some of our readers.
- Regarding the Accusations that Pfizer Used Fake Data – Making the Covid Vaccine Appear Better than Reality
- According to the Director of Ichilov Hospital, Currently, the Pfizer Vaccine Has No Significance In the Prevention of Severe Illness
- What Comment Did Dr. Vladimir Zev Zelenko Make About the Covid Vax That Led to Reinstating the Ban on Him on Twitter, Earlier This Month?
- Regarding The Rejection by FDA Advisers Last Month of Mandating Booster Shots for Covid Except for those in High Risk Categories